Stryker (SYK) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$25.8B

Revenue (quarter)

$6.6B

Revenue growth (year over year)

+9.42%

Gross profit (trailing twelve months)

$16.8B

Gross margin

64.98%

Net income (trailing twelve months)

$3.7B

Net income (quarter)

$1.3B

Net income growth (year over year)

+44.34%

Net margin

14.43%

Return on equity

16.51%

EPS (trailing twelve months)

$9.73

Book value per share

$62.54

P/E (trailing twelve months)

28.97

Price to book

4.50

Debt to assets

49.95%

Payout ratio

40.03%

Dividend yield

1.25%

Company profile

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

• Is Stryker (SYK) profitable?

  Yes. Stryker earned $3.7B in net income over the trailing twelve months, a net margin of 14.43%.

• How much revenue does Stryker (SYK) make?

  Stryker generated $25.8B in revenue over the trailing twelve months, up 9.42% year over year.

• What is SYK's P/E ratio?

  Stryker trades at 29.0 times trailing twelve-month earnings, on an EPS of $9.73.

• How do I buy stock in Stryker (SYK)?

  SYK trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.